Top compounds associated with response to POLA1


Feature Type Standardized
Nominal ANOVA
mRNA PD318088 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA etoposide CTRPv2 pan-cancer AAC 0.16 3e-07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA clofarabine CTRPv2 pan-cancer AAC 0.15 4e-07
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.19 6e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 7e-07
mRNA Topotecan CTRPv2 pan-cancer AAC 0.16 9e-07
Download CSV